01—Abstract
Summary
Summary of the 10-K filed February 27, 2023. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. reported strong performance for the fiscal year ended December 31, 2022, with total revenues reaching $5.02 billiona, a 7% increase year-over-year.
This growth was primarily driven by a 10%b rise in clearing and transaction fees, which benefited from an 18% increase in total contract volume. Key drivers for the volume increase included higher volatility in interest rate and equity index markets, influenced by inflation and Federal Reserve monetary policy. The company also saw a 6% increase in market data and information services revenue.
Despite higher licensing and fee agreements expenses, total operating expenses decreased by 2%c due to lower compensation and benefits costs, and professional fees. This led to an improved operating margin of 60.1%.
Net income attributable to CME Group rose by 2% to $2.69 billiond, resulting in diluted earnings per share of $7.40. The company also demonstrated robust cash flow from operations, increasing by 27% to $3.06 billion, supporting strategic investments and shareholder returns.
02—Key points
Key Highlights
- Total revenues increased by 7% to $5.02 billion in 2022.
- Clearing and transaction fees grew by 10% to $4.14 billion, driven by an 18% increase in total contract volume.
- Interest rate and equity index products experienced significant volume growth due to market volatility.
- Operating expenses decreased by 2% year-over-year, leading to an improved operating margin of 60.1%.
- Net income attributable to CME Group increased by 2% to $2.69 billion, with diluted EPS of $7.40.
- Cash flow from operations increased by 27% to $3.06 billion.
- The company made a strategic investment of $410 million in S&P Dow Jones Indices LLC.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2022filed February 27, 2023Financial Statements
FY2022 against FY2021
| Line item | FY2022FY2021 | Change |
|---|---|---|
| Revenue | $5.02B$4.69B | +7.0% |
| Operating Expenses | $2.00B$2.04B | −2.0% |
| Operating Income | $3.02B$2.65B | +14.0% |
| Net Income | $2.69B$2.64B | +2.0% |
| EPS (Basic) | $7.41$7.30 | +1.5% |
| EPS (Diluted) | $7.40$7.29 | +1.5% |
| Shares Outstanding (Basic) | 358.71M358.34M | +0.1% |
| Shares Outstanding (Diluted) | 359.18M358.93M | +0.1% |
05—Questions
Frequently Asked Questions
What was CME Group's revenue performance in 2022?
CME Group's total revenues increased by 7% to $5.02 billion in 2022, primarily driven by a 10% increase in clearing and transaction fees due to higher contract volumes and a 6% increase in market data and information services revenue.
What drove the increase in contract volume for CME Group in 2022?
The 18% increase in total contract volume was largely influenced by higher market volatility in interest rate and equity index products, stemming from inflation concerns and changes in Federal Reserve interest rate policy. Geopolitical uncertainty also played a role.
How did CME Group manage its expenses in 2022?
CME Group successfully reduced its total operating expenses by 2% in 2022. This reduction was mainly due to lower compensation and benefits costs, fewer professional fees and outside services, and a decrease in amortization expenses. This expense management contributed to an improved operating margin of 60.1%.
What is the outlook for CME Group's key product lines?
The company saw strong performance in interest rate and equity index products, with notable volume increases driven by market volatility. While agricultural commodities, energy, and metals saw slight decreases in volume, likely due to risk aversion and global trade uncertainty, the overall diversification across asset classes supports a resilient business model.
06—Continue